ReD worked with Cognizant, taking an outside-in perspective to study the phenomenon of healing.

More life sciences companies should build their R&D on the unmet needs of patients in real world contexts.

Pharmaceutical companies should take a closer look at how they create value. In a world of value-based health care, the answer goes beyond developing a new drug.

As medical understanding around body weight and related medical problems has increased, obesity has become a healthcare concern as well as an aesthetic one.

To understand and diagnose an illness requires acknowledging the ecology in which it takes place and collecting multiple perspectives.

Understanding cultural differences is good for drug companies’ top lines, and also for pushing the boundaries of medical science.

When developers in wearables put less focus on creating long-term relationships with users, they can deliver more meaningful value to users in the moment.

ReD helped Coloplast understand a key insight about its users: that not all bodies are shaped the same.

Pharma companies are taking steps toward "patient-centric" healthcare by using patient insights to guide drug development and clinical trials.